Avant Bio
North America, New York, United States, New York
Description
Early stage and growth equity investment firm focused on Healthtech, Tech Bio and Life Sciences across all stages.
Investor Profile
Avant Bio has made 3 investments, with 3 in the past 12 months and 33% as lead.
Stage Focus
- Series A (67%)
- Series B (33%)
Country Focus
- Germany (33%)
- United States (33%)
- Canada (33%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Health Diagnostics
- Market Research
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
